University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Red Sucroferric oxyhydroxide (Velphoro)

2nd or 3rd line agent.

Specialist use.

Status: Red Sugammadex

Restricted use as per protocol

Status: Amber Sulfasalazine

ESCA

Status: Red Sulindac tablets

Polyhydramnios (women only)

Status: Amber Sulpiride tablets

ESCA

Status: Red Sunitinib capsules

Hospital use only

Status: Red Tacrolimus 0.1% w/w in OrabaseTM

Unlicensed special

Status: Red Tacrolimus 0.3% w/w in OrabaseTM

Unlicensed special

Status: Red Tacrolimus capsules (Prograf)

New post-transplant

Status: Amber Tacrolimus capsules (Prograf)

Post-transplant pre 2015

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top